HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto Culver Will Sustain Ad Spend In 2009, Mull Direction To Take Noxzema

This article was originally published in The Rose Sheet

Executive Summary

Alberto Culver will continue to invest in its brands in order to stay on top of the hair-care category in the U.S., execs indicated during an Oct. 27 fourth-quarter and year-end earnings call

You may also be interested in...



It's Simple: Alberto Culver Grows Skin-Care Portfolio In U.K. To Match Hair Biz

In keeping with its strategy to grow the skin-care side of its business, Melrose Park, Ill.-based Alberto Culver will purchase Simple Health & Beauty Limited - the U.K.'s second-largest skin-care brand - from private equity firm Duke Street, it announced Dec. 14

It's Simple: Alberto Culver Grows Skin-Care Portfolio In U.K. To Match Hair Biz

In keeping with its strategy to grow the skin-care side of its business, Melrose Park, Ill.-based Alberto Culver will purchase Simple Health & Beauty Limited - the U.K.'s second-largest skin-care brand - from private equity firm Duke Street, it announced Dec. 14

Alberto-Culver's Noxzema Quality Issues Traced To P&G Facility; Suit Filed

A lawsuit filed by Alberto-Culver against Procter & Gamble - over the Noxzema brand each has parented - bears further testimony to quality control issues at P&G's manufacturing plant in Puerto Rico, which drew an FDA warning letter in April

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel